Market Research Report
Negative Pressure Wound Therapy (NPWT) Devices: Global Markets
|Published by||BCC Research||Product code||990086|
|Published||Content info||114 Pages
Delivery time: 1-2 business days
|Negative Pressure Wound Therapy (NPWT) Devices: Global Markets|
|Published: February 17, 2021||Content info: 114 Pages||
The global market for NPWT devices should grow from $2.3 billion in 2020 to $3.3 billion by 2025, at a compound annual growth rate (CAGR) of 7.8% for the period of 2020-2025.
Reusable NPWT devices market should grow from $1.5 billion in 2020 to $2.1 billion by 2025 at a CAGR of 7.1% through 2025.
Single-use NPWT devices market should grow from $833.1 million in 2020 to $1.3 billion by 2025 at a CAGR of 9.1% through 2025.
This report examines the current and projected market potential of NPWT devices. It offers a detailed analysis of the competitive environment, pipeline analysis, market background, technological advancement, drivers and restraints, and market growth trends. The report also includes market projections to 2025 and market ranks for key market players. The report details the market share of NPWT devices based on the type of product and application.
Based on product, the market is fragmented into single-use NPWT devices and reusable NPWT devices. By application, the market is segmented into chronic wounds and acute wounds. The NPWT devices consist of a vacuum pump, drainage tubing and a dressing set. Extra dressings, drapes and canisters used for further wound procedures are not considered in the scope of this report.
By geography, the market has been segmented into North America, Europe, the Asia-Pacific region and the Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2019 as the base year, 2020 and forecast through year-end 2025. Estimated values used are based on NPWT device manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.